PMID: 6983765Aug 1, 1982Paper

Fluid therapy for gastrointestinal, pancreatic, and hepatic disorders

The Veterinary Clinics of North America. Small Animal Practice
D C Twedt, G F Grauer

Abstract

Patients with gastrointestinal, hepatic, or pancreatic disease frequently require parenteral fluid therapy. The selection of the type and amount of fluid for administration should be based on a knowledge of physiologic derangements and the controlling mechanisms. Table 4 provides suggested replacement fluids and supplements for each disease. It must be remembered, however, that individual "tailoring" is required for each case. In addition to an expert knowledge of pathophysiology, monitoring of the patient's weight, fluid losses, serum electrolyte, and acid-base status is necessary for successful fluid therapy. In veterinary medicine the most common cause of inadequate fluid therapy is a deviation in the amount of fluid that the patient receives from the intended amount that may have been ever so carefully calculated.

References

Feb 1, 1976·Clinical Science and Molecular Medicine·V MirkovitchS Gomba
Aug 1, 1980·The Veterinary Clinics of North America. Small Animal Practice·R J Kolata

❮ Previous
Next ❯

Citations

Jan 1, 1985·The Veterinary Clinics of North America. Small Animal Practice·G F Grauer, C E Nichols
Jan 1, 1985·The Veterinary Clinics of North America. Small Animal Practice·D C Twedt
Mar 1, 1989·The Veterinary Clinics of North America. Small Animal Practice·K J Wolfsheimer
Aug 1, 1983·The Veterinary Clinics of North America. Small Animal Practice·D C Twedt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Veterinary Clinics of North America. Equine Practice
R J Rose
The Veterinary Clinics of North America. Small Animal Practice
G N Mauldin
The Journal of Rheumatology
R A WattsB L Hazleman
The Orthopedic Clinics of North America
C M Stiles
© 2021 Meta ULC. All rights reserved